Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-03 4:01 pm Purchase | 2023-06-21 | 13G | Clene Inc. CLNN | Citadel Advisors LLC | 381,220 5.700% | 381,220 (New Position) | Filing History |
| 2023-06-12 5:23 pm Purchase | 2023-05-31 | 13G | Lyra Therapeutics, Inc. LYRA | Citadel Advisors LLC | 57,931 5.900% | 57,931 (New Position) | Filing History |
| 2023-06-09 4:28 pm Purchase | 2023-05-30 | 13G | Inflection Point Acquisition Corp. II IPXXU | Citadel Advisors LLC | 1,500,608 6.000% | 1,500,608 (New Position) | Filing History |
| 2023-06-05 4:25 pm Purchase | 2023-05-25 | 13G | Icosavax, Inc. ICVX | Citadel Advisors LLC | 2,189,469 5.300% | 2,189,469 (New Position) | Filing History |
| 2023-05-19 4:06 pm Purchase | 2023-05-09 | 13G | Acelyrin, Inc. SLRN | Citadel Advisors LLC | 5,963,800 6.100% | 5,963,800 (New Position) | Filing History |
| 2023-05-19 4:05 pm Purchase | 2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP | Citadel Advisors LLC | 2,259,741 4.900% | 875,242 (+63.22%) | Filing History |
| 2023-05-19 4:04 pm Purchase | 2023-05-09 | 13G | Alchemy Investments Acquisition Corp 1 ALCYU | Citadel Advisors LLC | 663,323 5.500% | 663,323 (New Position) | Filing History |
| 2023-05-19 09:15 am Purchase | 2023-05-18 | 13G | Coherus Oncology, Inc. CHRS | Citadel Advisors LLC | 5,815,074 6.200% | 5,815,074 (New Position) | Filing History |
| 2023-05-15 4:47 pm Purchase | 2023-05-03 | 13G | Magenta Therapeutics, Inc. MGTA | Citadel Advisors LLC | 4,087,110 6.700% | 4,087,110 (New Position) | Filing History |
| 2023-05-01 4:49 pm Purchase | 2023-04-19 | 13G | 2seventy bio, Inc. TSVT | Citadel Advisors LLC | 2,591,606 5.200% | 2,591,606 (New Position) | Filing History |
| 2023-04-03 4:55 pm Purchase | 2023-03-23 | 13G | Design Therapeutics, Inc. DSGN | Citadel Advisors LLC | 2,871,267 5.100% | 203,037 (+7.61%) | Filing History |
| 2023-03-14 09:15 am Purchase | 2023-03-13 | 13G | Western Alliance Bancorporation WAL | Citadel Advisors LLC | 5,935,538 5.400% | 5,935,538 (New Position) | Filing History |
| 2023-03-06 4:11 pm Purchase | 2023-02-23 | 13G | Enliven Therapeutics, Inc. ELVN | Citadel Advisors LLC | 2,298,756 5.600% | 2,298,756 (New Position) | Filing History |
| 2023-02-27 4:02 pm Purchase | 2023-02-16 | 13G | Annexon, Inc. ANNX | Citadel Advisors LLC | 2,500,307 5.200% | 1,018,285 (+68.71%) | Filing History |
| 2023-02-14 09:52 am Sale | 2022-12-31 | 13G | StoneBridge Acquisition Corporation APAC | Citadel Advisors LLC | 625,412 3.100% | -1,054,173 (-62.76%) | Filing History |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | Oklo Inc. OKLO | Citadel Advisors LLC | 2,500,083 4.900% | -624,762 (-19.99%) | Filing History |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | Forum Merger IV Corporation FMIV | Citadel Advisors LLC | 1,476,226 4.300% | -312,588 (-17.47%) | Filing History |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | Fusion Acquisition Corp. II FSNB | Citadel Advisors LLC | 1,026,694 2.100% | -2,273,876 (-68.89%) | Filing History |
| 2023-02-14 08:26 am Sale | 2022-12-31 | 13G | Future Health ESG Corp. FHLT | Citadel Advisors LLC | 109,397 1.700% | -1,551,857 (-93.41%) | Filing History |
| 2023-02-14 08:26 am Purchase | 2022-12-31 | 13G | Gores Holdings IX, Inc. GHIX | Citadel Advisors LLC | 1,879,753 3.600% | 1,879,753 (New Position) | Filing History |